Table 3.
Posttransplantation events and causes of graft loss in the study perioda
| Parameter | Group 1 (n = 40) | Group 2 (n = 39) | P |
|---|---|---|---|
| Events (n [%]) | |||
| ureteral stent | 29 (73) | 15 (38) | 0.001 |
| DGF | 10 (25) | 8 (21) | 0.95 |
| acute rejection | 10 (25) | 7 (18) | 0.67 |
| surgical complication | 6 (15) | 5 (13) | 0.96 |
| proteinuria | 17 (43) | 14 (36) | 0.89 |
| ACEI/ARB treatment | 20 (50) | 21 (54) | 0.55 |
| Total graft loss (n [%]) | 14 (35) | 14 (36) | 0.87 |
| Causes of graft loss | 0.83 | ||
| DWFG | 5 | 5 | |
| FSGS | 2 | 3 | |
| CAN | 1 | 3 | |
| rejection | 2 | 1 | |
| infection | 1 | 1 | |
| TMA | 1 | 1 | |
| thrombosis | 2 | 0 |
a
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CAN, chronic allograft nephropathy; DGF, delayed graft function; DWFG, death with functioning graft; TMA, thrombotic microangiopathy.